Pilocarpine treatments differentially affect alpha(2)-adrenoceptors which modulate the firing rate of locus coeruleus neurones and the synthesis and release of noradrenaline in rat brain

Citation
Ma. Garro et al., Pilocarpine treatments differentially affect alpha(2)-adrenoceptors which modulate the firing rate of locus coeruleus neurones and the synthesis and release of noradrenaline in rat brain, PHARM TOX, 85(2), 1999, pp. 74-79
Citations number
34
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGY & TOXICOLOGY
ISSN journal
09019928 → ACNP
Volume
85
Issue
2
Year of publication
1999
Pages
74 - 79
Database
ISI
SICI code
0901-9928(199908)85:2<74:PTDAAW>2.0.ZU;2-R
Abstract
We have investigated the effect of treatments with the muscarinic acetylcho line receptor agonist, pilocarpine, on the sensitivity of central alpha(2)- adrenoceptors that regulate the firing activity of rat locus coeruleus, the tyrosine hydroxylase activity in the rat cortex, hippocampus and hypothala mus, and the K+-evoked release of [H-3]noradrenaline from rat cortical and hippocampal synaptosomes. Short-term (4 days), but not acute, treatment wit h pilocarpine caused a small but statistically significant increase in the inhibitory effect of the alpha(2)-adrenoceptor agonist clonidine on the fir ing rate of locus coeruleus neurones, with a decrease in the ED50 Of 29% (P <0.001). However, no change in the effect of clonidine on the locus coerule us was observed after longer pilocarpine(ll days) treatment. In the rat cer ebral cortex, but not in hippocampus or hypothalamus, chronic (19 days) tre atment with pilocarpine caused a decrease in the inhibitory effect of cloni dine on tyrosine hydroxylase activity (55%, P<0.05), but did not change the stimulatory effect of the alpha(2)-adrenoceptor antagonist idazoxan. Moreo ver, treatments (4, 11 and 19 days) with pilocarpine did not alter the inhi bitory effect of clonidine [10(-8)-10(-5) RI] on the K+-evoked release of [ H-3]noradrenaline from rat cortical and hippocampal synaptosomes. These res ults indicate that administration of pilocarpine slightly potentiates some but not all the functional responses mediated by brain presynaptic alpha(2) -adrenoceptors. In conclusion, these results do not support the hypothesis that chronic treatments with pilocarpine lead to a suitable model of alpha( 2)-adrenoceptor supersensitivity.